Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Partnering
Management Team
Board of Directors
Product Pipeline
Overview
PCS3117
PCS6422
PCS11T
Publications
Our Clinical Trials
Overview
PCS6422
News & Media
Press Releases
Presentations
Events
In The News
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
Careers
Presentations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Analyst Coverage
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Mar 28, 2025
Investor Slide Deck – March 2025
Feb 11, 2025
Investor Slide Deck – February 2025
Aug 26, 2024
Investor Presentation
Apr 3, 2024
Corporate Presentation
Mar 1, 2024
Corporate Presentation
Jan 11, 2024
Corporate Presentation
Dec 5, 2023
Next Generation Chemotherapy: Improved Treatment for More Patients
Nov 16, 2023
Benefit-Risk Analysis for FDA Approval Requires More Than a Pivotal Trial
Nov 10, 2023
Investor Presentation
Jun 21, 2023
Next Generation Chemotherapy: Improved Treatment for More Patients
1
2
3
Next
Email Alerts
Contacts
RSS News Feed
